RÉSUMÉ
OBJECTIVES: The diagnostic performance of fractional flow reserve with computed tomography (FFR-CT) is affected by the presence of calcified plaque. Subtraction can remove the influence of calcification in coronary computed tomography angiography (CCTA) to increase confidence in the diagnosis of coronary artery stenosis. Our purpose is to investigate the accuracy of post-subtraction FFR-CT in predicting early revascularization. DESIGN: Based on CCTA data of 237 vessels from 79 patients with coronary artery disease, subtraction CCTA images were obtained at a local post-processing workstation, and the conventional and post-subtraction FFR-CT measurements and the difference in proximal and distal FFR-CT values of the narrowest segment of the vessel (ΔFFR-CT) were analyzed for their accuracy in predicting early coronary artery hemodynamic reconstruction. RESULTS: With FFR-CT ≤ 0.8 as the criterion, the accuracy of conventional and post-subtraction FFR-CT measurements in predicting early revascularization was 73.4% and 77.2% at the patient level, and 64.6% and 72.2% at the vessel level, respectively. The specificity of post-subtraction FFR-CT measurements was significantly higher than that of conventional FFR-CT at both the patient and vessel levels (P of 0.013 and 0.015, respectively). At the vessel level, the area under the curve of receiver operating characteristic was 0.712 and 0.797 for conventional and post-subtraction ΔFFR-CT, respectively, showing a difference (P = 0.047), with optimal cutoff values of 0.07 and 0.11, respectively. CONCLUSION: The post-subtraction FFR-CT measurements enhance the specificity in predicting early revascularization. The post-subtraction ΔFFR-CT value of the stenosis segment > 0.11 may be an important indicator for early revascularization.
Sujet(s)
Angiographie par tomodensitométrie , Coronarographie , Maladie des artères coronaires , Sténose coronarienne , Fraction du flux de réserve coronaire , Revascularisation myocardique , Valeur prédictive des tests , Humains , Mâle , Femelle , Adulte d'âge moyen , Sujet âgé , Maladie des artères coronaires/physiopathologie , Maladie des artères coronaires/imagerie diagnostique , Maladie des artères coronaires/thérapie , Sténose coronarienne/imagerie diagnostique , Sténose coronarienne/physiopathologie , Sténose coronarienne/thérapie , Reproductibilité des résultats , Vaisseaux coronaires/physiopathologie , Vaisseaux coronaires/imagerie diagnostique , Calcification vasculaire/imagerie diagnostique , Calcification vasculaire/physiopathologie , Calcification vasculaire/thérapie , Études rétrospectives , Tomodensitométrie multidétecteurs , Indice de gravité de la maladie , Délai jusqu'au traitement , Angiographie de soustraction digitaleSujet(s)
Techniques de coculture , Cellules endothéliales , Muscles lisses vasculaires , Myocytes du muscle lisse , Calcification vasculaire , Humains , Myocytes du muscle lisse/anatomopathologie , Myocytes du muscle lisse/métabolisme , Calcification vasculaire/anatomopathologie , Calcification vasculaire/physiopathologie , Calcification vasculaire/métabolisme , Muscles lisses vasculaires/métabolisme , Muscles lisses vasculaires/physiopathologie , Muscles lisses vasculaires/anatomopathologie , Animaux , Cellules endothéliales/métabolisme , Cellules endothéliales/anatomopathologie , Cellules cultivéesRÉSUMÉ
PURPOSE: Intraplaque haemorrhage (IPH) is a well-known risk factor for faster plaque progression (volume increase); however, its etiology is unclear. We aimed at determining what other local plaque- and systemic factors contribute to plaque progression and to the development and progression of IPH. METHODS: We examined 98 asymptomatic participants with carotid plaque using serial multi-contrast magnetic resonance imaging. We measured the percent of wall volume (%WV=100 x [wall volume] / [total vessel volume]) and measured IPH and calcification volumes. We used generalized estimating equations-based regression to analyze predictors of %WV change and new IPH while accounting for covariates (sex, age and statin use), and multiple non-independent observations per participant. RESULTS: Total follow-up was 1.8 ± 0.8 years on average. The presence of IPH (ß: 0.6 %/y, p = 0.033) and calcification (ß: 1.2 %/y, p = 0.028) were each associated with faster plaque progression. New IPH, detected on a subsequent scan in 4 % of arteries that did not initially have IPH, was associated with larger calcification (odds ratio [OR]: 2.6 per 1-SD increase, p = 0.038) and higher pulse pressure (OR: 2.3 per 1-SD increase, p = 0.016). Larger calcification was associated with greater increases in pulse pressure (ß: 1.4 mm Hg/y per 1-SD increase, p = 0.040). CONCLUSIONS: IPH and calcification are each independently associated with faster plaque progression. The association of carotid calcification to increased pulse pressure and new IPH development suggests a possible mechanism by which calcification drives IPH development and plaque progression.
Sujet(s)
Pression sanguine , Artériopathies carotidiennes , Hémorragie , Humains , Mâle , Femelle , Artériopathies carotidiennes/imagerie diagnostique , Artériopathies carotidiennes/complications , Artériopathies carotidiennes/physiopathologie , Sujet âgé , Adulte d'âge moyen , Hémorragie/imagerie diagnostique , Hémorragie/physiopathologie , Évolution de la maladie , Facteurs de risque , Calcification vasculaire/imagerie diagnostique , Calcification vasculaire/physiopathologie , Calcification vasculaire/complications , Plaque d'athérosclérose/imagerie diagnostique , Reproductibilité des résultats , Sensibilité et spécificité , Imagerie par résonance magnétique/méthodes , Angiographie par résonance magnétiqueRÉSUMÉ
BACKGROUND: The coronary artery disease-reporting and data system (CAD-RADS) 2.0 is used to standardize the reporting of coronary computed tomography angiography (CCTA) results. Artificial intelligence software can quantify the plaque composition, fat attenuation index, and fractional flow reserve. OBJECTIVE: To analyze plaque features of varying severity in patients with a combination of CAD-RADS stenosis and plaque burden categorization and establish a random forest classification model. METHODS: The data of 100 patients treated between April 2021 and February 2022 were retrospectively collected. The most severe plaque observed in each patient was the target lesion. Patients were categorized into three groups according to CAD-RADS: CAD-RADS 1-2 + P0-2, CAD-RADS 3-4B + P0-2, and CAD-RADS 3-4B + P3-4. Differences and correlations between variables were assessed between groups. AUC, accuracy, precision, recall, and F1 score were used to evaluate the diagnostic performance. RESULTS: A total of 100 patients and 178 arteries were included. The differences of computed tomography fractional flow reserve (CT-FFR) (H = 23.921, p < 0.001), the volume of lipid component (H = 12.996, p = 0.002), the volume of fibro-lipid component (H = 8.692, p = 0.013), the proportion of lipid component volume (H = 22.038, p < 0.001), the proportion of fibro-lipid component volume (H = 11.731, p = 0.003), the proportion of calcification component volume (H = 11.049, p = 0.004), and plaque type (χ2 = 18.110, p = 0.001) was statistically significant. CONCLUSION: CT-FFR, volume and proportion of lipid and fibro-lipid components of plaques, the proportion of calcified components, and plaque type were valuable for CAD-RADS stenosis + plaque burden classification, especially CT-FFR, volume, and proportion of lipid and fibro-lipid components. The model built using the random forest was better than the clinical model (AUC: 0.874 vs. 0.647).
Sujet(s)
Angiographie par tomodensitométrie , Coronarographie , Maladie des artères coronaires , Sténose coronarienne , Vaisseaux coronaires , Fraction du flux de réserve coronaire , Plaque d'athérosclérose , Indice de gravité de la maladie , Humains , Mâle , Femelle , Fraction du flux de réserve coronaire/physiologie , Études rétrospectives , Angiographie par tomodensitométrie/méthodes , Adulte d'âge moyen , Coronarographie/méthodes , Sténose coronarienne/physiopathologie , Sténose coronarienne/imagerie diagnostique , Sténose coronarienne/diagnostic , Maladie des artères coronaires/physiopathologie , Maladie des artères coronaires/diagnostic , Maladie des artères coronaires/imagerie diagnostique , Vaisseaux coronaires/imagerie diagnostique , Vaisseaux coronaires/physiopathologie , Calcification vasculaire/imagerie diagnostique , Calcification vasculaire/physiopathologie , Sujet âgéRÉSUMÉ
Objective: To investigate the association between body composition and coronary artery calcification in patients with chronic kidney disease (CKD). Methods: This cross-sectional study enrolled patients with CKD hospitalized from May 2019 to April 2022 at Sun Yat-sen Memorial Hospital, Guangzhou, China. Skeletal muscle mass index and visceral fat area were measured by bioelectrical impedance analysis. Coronary artery calcification was assessed by computed tomography. Patients were divided into coronary artery calcification group and non-coronary artery calcification group according to the incidence of coronary artery calcification. Patients were categorized into tertile groups according to their skeletal muscle mass index and visceral fat area levels ranging from the lowest to the highest levels (T1 to T3). We defined skeletal muscle mass index≤30.4% as low muscle mass and visceral fat area≥80.6 cm2 as high visceral fat based on the results of the restricted cubic spline graph. All individuals were divided into 4 phenotypes: normal body composition, low muscle mass, high visceral fat, and low muscle mass with high visceral fat. Spearman correlation analysis and logistic regression analysis were used to assess the association between skeletal muscle mass index, visceral fat area and coronary artery calcification. Results: A total of 107 patients with CKD were enrolled, with an age of (60.0±14.1) years, including 41 female patients (38.3%). Patients of coronary artery calcification group had lower skeletal muscle mass index ((32.0±4.8) vs. (34.3±4.8), P=0.016) and higher visceral fat area ((70.8±32.6) cm2 vs. (47.9±23.8) cm2, P<0.001) than those of non-coronary artery calcification group. Patients in the T3 group of skeletal muscle mass index had a lower prevalence of coronary artery calcification (17 (48.6%) vs. 28 (77.8%)) and a lower coronary artery calcification score (0.5 (0, 124.0) vs. 12.0 (0.3, 131.0)) than those in the T1 group (P<0.05). Similarly, patients in the T1 group of visceral fat area had a lower prevalence of coronary artery calcification (14 (40.0%) vs. 29 (80.6%)) and a lower coronary artery calcification score (0 (0, 3.0) vs. 37.0 (2.0, 131.0)) than those in the T3 group (P<0.05). Likewise, patients with both low muscle mass and low muscle mass with high visceral fat had a higher prevalence of coronary artery calcification (11(78.6%) vs. 33 (47.8%); 15 (83.3%) vs. 33 (47.8%)) and a higher coronary artery calcification score (31.1 (0.8, 175.8) vs. 0 (0, 16.4); 27.6 (6.4, 211.4) vs. 0 (0, 16.4)) than those with normal body composition (P<0.05). Spearman correlation analysis showed that skeletal muscle mass index was inversely correlated with coronary artery calcification score (r=-0.212, P=0.028), and visceral fat area was positively correlated with coronary artery calcification score (r=0.408, P<0.001). Multivariate logistic regression analysis showed that increased skeletal muscle mass index was inversely associated with coronary artery calcification prevalence (T2: OR=0.208, 95%CI: 0.056-0.770, P=0.019; T3: OR=0.195, 95%CI: 0.043-0.887, P=0.034), and reduced visceral fat area was inversely associated with coronary artery calcification prevalence (T1: OR=0.256, 95%CI: 0.071-0.923, P=0.037; T2: OR=0.263, 95%CI: 0.078-0.888, P=0.031). Consistently, both low muscle mass and low muscle mass with high visceral fat were associated with coronary artery calcification prevalence (OR=6.616, 95%CI: 1.383-31.656, P=0.018; OR=5.548, 95%CI: 1.062-28.973, P=0.042). Conclusion: Reduced skeletal muscle mass index and increased visceral fat area are significantly associated with both the prevalence and severity of coronary artery calcification in patients with CKD.
Sujet(s)
Composition corporelle , Maladie des artères coronaires , Graisse intra-abdominale , Insuffisance rénale chronique , Calcification vasculaire , Humains , Études transversales , Insuffisance rénale chronique/complications , Insuffisance rénale chronique/physiopathologie , Maladie des artères coronaires/complications , Maladie des artères coronaires/physiopathologie , Graisse intra-abdominale/imagerie diagnostique , Calcification vasculaire/imagerie diagnostique , Calcification vasculaire/complications , Calcification vasculaire/physiopathologie , Muscles squelettiques/imagerie diagnostique , Muscles squelettiques/physiopathologie , Vaisseaux coronaires/imagerie diagnostique , Vaisseaux coronaires/anatomopathologie , Mâle , Femelle , Adulte d'âge moyenRÉSUMÉ
BACKGROUND: Patients with myocardial ischemia without obstructive coronary artery disease often have coronary microvascular dysfunction (CMD) and associated increased risk of cardiovascular (CV) events and anginal hospitalizations. Epicardial adipose tissue (EAT) covers much of the myocardium and coronary arteries and when dysfunctional, secretes proinflammatory cytokines and is associated with CV events. While oxidative stress and systemic inflammation are associated with CMD, the relationship between EAT and CMD in women is not well known. METHODS: Women diagnosed with CMD (n = 21) who underwent coronary computed tomography with coronary artery calcium (CAC) scoring were compared to a reference group (RG) of women referred for CAC screening for preventive risk assessment (n = 181). EAT attenuation (Hounsfield units (HU)) was measured adjacent to the proximal right coronary artery, along with subcutaneous adipose tissue (SCAT). Two-sample t-tests with unequal variances were utilized. RESULTS: Mean age of the CMD group was 56 ± 8 years and body mass index (BMI) was 31.6 ± 6.8 kg/m2. CV risk factors in the CMD group were prevalent: 67 % hypertension, 44 % hyperlipidemia, and 33 % diabetes. Both CMD and RG had similar CAC score (25.86 ± 59.54 vs. 24.17 ± 104.6; p = 0.21. In the CMD group, 67 % had a CAC of 0. Minimal atherosclerosis (CAD-RADS 1) was present in 76 % of women with CMD. The CMD group had lower EAT attenuation than RG (-103.3 ± 6.33 HU vs. -97.9 ± 8.3 HU, p = 0.009, respectively). There were no differences in SCAT attenuation. Hypertension, smoking history, age, BMI, and CAC score did not correlate with EAT in either of the groups. CONCLUSIONS: Women with CMD have decreased EAT attenuation compared to RG women. EAT-mediated inflammation and changes in vascular tone may be a mechanistic contributor to abnormal microvascular reactivity. Clinical trials testing therapeutic strategies to decrease EAT may be warranted in the management of CMD.
Sujet(s)
Tissu adipeux , Angiographie par tomodensitométrie , Coronarographie , Maladie des artères coronaires , Circulation coronarienne , Vaisseaux coronaires , Microcirculation , Péricarde , Humains , Femelle , Adulte d'âge moyen , Péricarde/imagerie diagnostique , Tissu adipeux/imagerie diagnostique , Projets pilotes , Maladie des artères coronaires/imagerie diagnostique , Maladie des artères coronaires/physiopathologie , Vaisseaux coronaires/imagerie diagnostique , Vaisseaux coronaires/physiopathologie , Sujet âgé , Facteurs de risque de maladie cardiaque , Microvaisseaux/imagerie diagnostique , Microvaisseaux/physiopathologie , Valeur prédictive des tests , Calcification vasculaire/imagerie diagnostique , Calcification vasculaire/physiopathologie ,RÉSUMÉ
BACKGROUND: Vascular calcification is associated with increased mortality in patients with cardiovascular disease. Secondary calciprotein particles are believed to play a causal role in the pathophysiology of vascular calcification. The maturation time (T50) of calciprotein particles provides a measure of serum calcification propensity. We compared T50 between patients with ST-segment-elevated myocardial infarction and control subjects and studied the association of T50 with cardiovascular risk factors and outcome. METHODS: T50 was measured by nephelometry in 347 patients from the GIPS-III trial (Metabolic Modulation With Metformin to Reduce Heart Failure After Acute Myocardial Infarction: Glycometabolic Intervention as Adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction: a Randomized Controlled Trial) and in 254 matched general population controls from PREVEND (Prevention of Renal and Vascular End-Stage Disease). We also assessed the association between T50 and left ventricular ejection fraction, as well as infarct size, the incidence of ischemia-driven reintervention during 5 years of follow-up, and serum nitrite as a marker of endothelial dysfunction. RESULTS: Patients with ST-segment-elevated myocardial infarction had a significantly lower T50 (ie, higher serum calcification propensity) compared with controls (T50: 289±63 versus 338±56 minutes; P<0.001). In patients with ST-segment-elevated myocardial infarction, lower T50 was associated with female sex, lower systolic blood pressure, lower total cholesterol, lower LDL (low-density lipoprotein) cholesterol, lower triglycerides, and higher HDL (high-density lipoprotein) cholesterol but not with circulating nitrite or nitrate. Ischemia-driven reintervention was associated with higher LDL (P=0.03) and had a significant interaction term for T50 and sex (P=0.005), indicating a correlation between ischemia-driven reintervention and T50 above the median in men and below the median in women, between 150 days and 5 years of follow-up. CONCLUSIONS: Serum calcification propensity is increased in patients with ST-segment-elevated myocardial infarction compared with the general population, and its contribution is more pronounced in women than in men. Its lack of/inverse association with nitrite and blood pressure confirms T50 to be orthogonal to traditional cardiovascular disease risk factors. Lower T50 was associated with a more favorable serum lipid profile, suggesting the involvement of divergent pathways of calcification stress and lipid stress in the pathophysiology of myocardial infarction.
Sujet(s)
Infarctus du myocarde avec sus-décalage du segment ST , Humains , Mâle , Femelle , Adulte d'âge moyen , Sujet âgé , Infarctus du myocarde avec sus-décalage du segment ST/sang , Infarctus du myocarde avec sus-décalage du segment ST/physiopathologie , Marqueurs biologiques/sang , Facteurs de risque de maladie cardiaque , Calcification vasculaire/sang , Calcification vasculaire/physiopathologie , Appréciation des risques , Facteurs de risque , Études cas-témoins , Facteurs temps , Fonction ventriculaire gauche , Débit systoliqueRÉSUMÉ
A 66-year-old man with multiple comorbidities including severe peripheral artery disease and heart failure with reduced ejection fraction presented with complex coronary artery disease with an elevated Society of Thoracic Surgeons Predicted Risk of Mortality for coronary artery bypass grafting and a Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery score of 18. With a multidisciplinary heart team approach, the patient successfully underwent percutaneous axillary venoarterial extracorporeal membrane oxygenation (VA-ECMO) supported high-risk percutaneous coronary intervention of a heavily calcified left main bifurcation lesion. Given the patient's peripheral artery disease, alternative arterial access for ECMO cannulation was performed percutaneously via the right axillary artery. Additionally, adequate coronary calcium modification was critical to successful stenting of a heavily calcified left main bifurcation. This case highlights a novel approach to obtaining alternative arterial access for ECMO cannulation and emphasizes the importance of calcium modification to achieve excellent stent results.
Sujet(s)
Artère axillaire , Maladie des artères coronaires , Oxygénation extracorporelle sur oxygénateur à membrane , Calcification vasculaire , Humains , Mâle , Sujet âgé , Résultat thérapeutique , Artère axillaire/imagerie diagnostique , Maladie des artères coronaires/thérapie , Maladie des artères coronaires/imagerie diagnostique , Calcification vasculaire/thérapie , Calcification vasculaire/imagerie diagnostique , Calcification vasculaire/physiopathologie , Intervention coronarienne percutanée/instrumentation , Intervention coronarienne percutanée/effets indésirables , Cathétérisme périphérique , Maladie artérielle périphérique/thérapie , Maladie artérielle périphérique/imagerie diagnostique , Maladie artérielle périphérique/physiopathologie , Endoprothèses , CoronarographieRÉSUMÉ
Currently, more and more people are suffering from chronic kidney disease (CKD). It is estimated that CKD affects over 10% of the population worldwide. This is a significant issue, as the kidneys largely contribute to maintaining homeostasis by, among other things, regulating blood pressure, the pH of blood, and the water-electrolyte balance and by eliminating unnecessary metabolic waste products from blood. What is more, this disease does not show any specific symptoms at the beginning. The development of CKD is predisposed by certain conditions, such as diabetes mellitus or hypertension. However, these disorders are not the only factors promoting the onset and progression of CKD. The primary purpose of this review is to examine renin-angiotensin-aldosterone system (RAAS) activity, transforming growth factor-ß1 (TGF-ß1), vascular calcification (VC), uremic toxins, and hypertension in the context of their impact on the occurrence and the course of CKD. We firmly believe that a deeper comprehension of the cellular and molecular mechanisms underlying CKD can lead to an enhanced understanding of the disease. In the future, this may result in the development of medications targeting specific mechanisms involved in the decline of kidney function. Our paper unveils the selected processes responsible for the deterioration of renal filtration abilities.
Sujet(s)
Évolution de la maladie , Insuffisance rénale chronique , Système rénine-angiotensine , Humains , Insuffisance rénale chronique/anatomopathologie , Insuffisance rénale chronique/métabolisme , Système rénine-angiotensine/physiologie , Animaux , Hypertension artérielle/physiopathologie , Hypertension artérielle/anatomopathologie , Calcification vasculaire/métabolisme , Calcification vasculaire/anatomopathologie , Calcification vasculaire/physiopathologie , Facteur de croissance transformant bêta-1/métabolisme , Rein/anatomopathologie , Rein/métabolisme , Rein/physiopathologieRÉSUMÉ
BACKGROUND: Chronic kidney disease (CKD) is associated with accelerated vascular calcification and increased central systolic blood pressure when measured invasively (invCSBP) relative to cuff-based brachial systolic blood pressure (cuffSBP). The contribution of aortic wall calcification to this phenomenon has not been clarified. We, therefore, examined the effects of aortic calcification on cuffSBP and invCSBP in a cohort of patients representing all stages of CKD. METHODS: During elective coronary angiography, invCSBP was measured in the ascending aorta with a fluid-filled catheter with simultaneous recording of cuffSBP using an oscillometric device. Furthermore, participants underwent a non-contrast computed tomography scan of the entire aorta with observer-blinded calcification scoring of the aortic wall ad modum Agatston. RESULTS: We included 168 patients (mean age 67.0â ±â 10.5, 38 females) of whom 38 had normal kidney function, while 30, 40, 28, and 32 had CKD stages 3a, 3b, 4, and 5, respectively. Agatston scores adjusted for body surface area ranged from 48 to 40,165. We found that invCSBP increased 3.6 (95% confidence interval 1.4-5.7) mm Hg relative to cuffSBP for every 10,000-increment in aortic Agatston score. This association remained significant after adjustment for age, diabetes, antihypertensive treatment, smoking, eGFR, and BP level. No such association was found for diastolic BP. CONCLUSIONS: Patients with advanced aortic calcification have relatively higher invCSBP for the same cuffSBP as compared to patients with less calcification. Advanced aortic calcification in CKD may therefore result in hidden central hypertension despite apparently well-controlled cuffSBP. ClinicalTrials.gov identifier: NCT04114695.
Sujet(s)
Mesure de la pression artérielle , Insuffisance rénale chronique , Calcification vasculaire , Humains , Femelle , Mâle , Sujet âgé , Adulte d'âge moyen , Insuffisance rénale chronique/physiopathologie , Insuffisance rénale chronique/complications , Insuffisance rénale chronique/diagnostic , Calcification vasculaire/imagerie diagnostique , Calcification vasculaire/physiopathologie , Mesure de la pression artérielle/méthodes , Maladies de l'aorte/physiopathologie , Maladies de l'aorte/imagerie diagnostique , Pression sanguine , Angiographie par tomodensitométrie , Artère brachiale/physiopathologie , Artère brachiale/imagerie diagnostique , Coronarographie , Aortographie , Valeur prédictive des testsRÉSUMÉ
BACKGROUND: Computed tomography attenuation correction (CTAC) improves perfusion quantification of hybrid myocardial perfusion imaging by correcting for attenuation artifacts. Artificial intelligence (AI) can automatically measure coronary artery calcium (CAC) from CTAC to improve risk prediction but could potentially derive additional anatomic features. OBJECTIVES: The authors evaluated AI-based derivation of cardiac anatomy from CTAC and assessed its added prognostic utility. METHODS: The authors considered consecutive patients without known coronary artery disease who underwent single-photon emission computed tomography/computed tomography (CT) myocardial perfusion imaging at 3 separate centers. Previously validated AI models were used to segment CAC and cardiac structures (left atrium, left ventricle, right atrium, right ventricular volume, and left ventricular [LV] mass) from CTAC. They evaluated associations with major adverse cardiovascular events (MACEs), which included death, myocardial infarction, unstable angina, or revascularization. RESULTS: In total, 7,613 patients were included with a median age of 64 years. During a median follow-up of 2.4 years (IQR: 1.3-3.4 years), MACEs occurred in 1,045 (13.7%) patients. Fully automated AI processing took an average of 6.2 ± 0.2 seconds for CAC and 15.8 ± 3.2 seconds for cardiac volumes and LV mass. Patients in the highest quartile of LV mass and left atrium, LV, right atrium, and right ventricular volume were at significantly increased risk of MACEs compared to patients in the lowest quartile, with HR ranging from 1.46 to 3.31. The addition of all CT-based volumes and CT-based LV mass improved the continuous net reclassification index by 23.1%. CONCLUSIONS: AI can automatically derive LV mass and cardiac chamber volumes from CT attenuation imaging, significantly improving cardiovascular risk assessment for hybrid perfusion imaging.
Sujet(s)
Intelligence artificielle , Angiographie par tomodensitométrie , Maladie des artères coronaires , Imagerie de perfusion myocardique , Valeur prédictive des tests , Tomographie par émission monophotonique couplée à la tomodensitométrie , Calcification vasculaire , Humains , Adulte d'âge moyen , Imagerie de perfusion myocardique/méthodes , Femelle , Mâle , Sujet âgé , Appréciation des risques , Maladie des artères coronaires/imagerie diagnostique , Maladie des artères coronaires/physiopathologie , Maladie des artères coronaires/mortalité , Pronostic , Facteurs de risque , Calcification vasculaire/imagerie diagnostique , Calcification vasculaire/physiopathologie , Coronarographie , Circulation coronarienne , Vaisseaux coronaires/imagerie diagnostique , Vaisseaux coronaires/physiopathologie , Facteurs temps , Interprétation d'images radiographiques assistée par ordinateur , Études rétrospectives , Reproductibilité des résultatsRÉSUMÉ
RATIONALE AND OBJECTIVES: Increased central (aortic) arterial stiffness has hemodynamic repercussions that affect the incidence of cardiovascular and renal disease. In chronic kidney disease (CKD) there may be an increase in aortic stiffness secondary to multiple metabolic alterations including calcification of the vascular wall (VC). The objective of this study was to analyze the association of central aortic pressures and aortic stiffness with the presence of VC in abdominal aorta (AAC) and coronary arteries(CAC). MATERIALS AND METHODS: We included 87 pacientes with CKD stage 3 and 4. Using applanation tonometry, central aortic pressures and aortic stiffness were studied. We investigated the association of aortic pulse wave velocity (Pvc-f) and Pvc-f adjusted for age, blood pressure, sex and heart rate (Pvc-f index) with AAC obtained on lumbar lateral radiography and CAC assessed by multidetector computed tomography. AAC and CAC were scored according to Kauppila and Agatston methods, respecti-vely. For the study of the association between Pvc-f index, Kauppila score, Agatston score, central aortic pressures, clinical parameters and laboratory data, multiple and logistic regression were used. We investigated the diagnosis performance of the Pvc-f index for prediction of VC using receiver-operating characteristic (ROC). RESULTS: Pvc-f and Pvc-f index were 11.3 ± 2.6 and 10.6 m/s, respectively. The Pvc-f index was higher when CKD coexisted with diabetes mellitus (DM). AAC and CAC were detected in 77% and 87%, respectively. Albuminuria (ß = 0.13, p = 0.005) and Kauppila score (ß = 0.36, p = 0.001) were independently associated with Pvc-f index. In turn, Pvc-f index (ß = 0.39, p = 0.001), DM (ß = 0.46, p = 0.01), and smoking (ß = 0.53; p = 0.006) were associated with Kauppila score, but only Pvc-f index predicted AAC [OR: 3.33 (95% CI: 1.6-6.9; p = 0.001)]. The Kauppila score was independently associated with the Agatston score (ß = 1.53, p = 0.001). The presence of AAC identified patients with CAC with a sensitivity of 73%, a specificity of 100%, a positive predictive value of 100% and a negative predictive value of 38%. The Vpc-f index predicted the presence of CAC [OR: 3.35 (95% CI: 1.04-10.2, p = 0.04)]. In the ROC curves, using the Vpc-f index, the AUC for AAC and CAC was 0.82 (95%CI: 0.71-0.93, p = 0.001) and 0.81 (95% CI: 0.67-0.96, p = 0.02), respectively. CONCLUSIONS: When stage 3-4 CKD coexists with DM there is an increase in aortic stiffness determined by the Vpc-f index. In stage 3-4 CKD, AAC and CAC are very prevalent and both often coexist. The Vpc-f index is independently associated with AAC and CAC and may be useful in identifying patients with VC in these territories.
Sujet(s)
Aorte abdominale , Insuffisance rénale chronique , Calcification vasculaire , Rigidité vasculaire , Humains , Mâle , Femelle , Adulte d'âge moyen , Insuffisance rénale chronique/complications , Insuffisance rénale chronique/physiopathologie , Calcification vasculaire/imagerie diagnostique , Calcification vasculaire/physiopathologie , Calcification vasculaire/étiologie , Aorte abdominale/imagerie diagnostique , Aorte abdominale/physiopathologie , Sujet âgé , Indice de gravité de la maladie , Études transversales , Analyse de l'onde de pouls , Maladie des artères coronaires/physiopathologie , Maladie des artères coronaires/imagerie diagnostique , Maladie des artères coronaires/complications , Maladies de l'aorte/imagerie diagnostique , Maladies de l'aorte/physiopathologie , Maladies de l'aorte/complications , Maladies de l'aorte/étiologieRÉSUMÉ
BACKGROUND AND AIMS: Vascular calcification has been linked to bone mineral density (BMD). This study aimed to investigate the association between BMD and abdominal aortic calcification (AAC). METHODS AND RESULTS: Data from the 2013-2014 National Health and Nutrition Examination Survey (NHANES) were utilized. Participants lacking BMD and AAC score data were excluded. BMD at the femoral neck was measured using dual-energy X-ray absorptiometry. AAC scores were assessed using the Kauppila scoring system, with AAC defined as a score greater than zero, and severe AAC defined as a score greater than six. Weighted multivariable regression analysis and subgroup analysis were conducted to examine the independent relationship between BMD and AAC score, AAC, and severe AAC. A total of 2965 participants were included. After adjusting for multiple covariates, BMD showed a negative association with higher AAC scores (ß = -0.17, 95% CI -0.29, -0.05, p = 0.0066). The odds of having AAC and severe AAC decreased by 9% and 16%, respectively, for every one-unit increase in BMD (AAC: odds ratio [OR] = 0.91, 95% CI 0.82, 1.00, p = 0.0431; severe AAC: OR = 0.84, 95% CI 0.71, 0.99, p = 0.0334). CONCLUSION: Low BMD is associated with higher AAC scores and an increased risk of AAC and severe AAC. Considering the detrimental impact of low BMD on cardiovascular health, individuals with AAC should be evaluated for osteopenia and osteoporosis in clinical settings.
Sujet(s)
Absorptiométrie photonique , Aorte abdominale , Maladies de l'aorte , Densité osseuse , Enquêtes nutritionnelles , Calcification vasculaire , Humains , Mâle , Femelle , Aorte abdominale/imagerie diagnostique , Aorte abdominale/physiopathologie , Adulte d'âge moyen , Calcification vasculaire/épidémiologie , Calcification vasculaire/imagerie diagnostique , Calcification vasculaire/physiopathologie , Maladies de l'aorte/épidémiologie , Maladies de l'aorte/imagerie diagnostique , Maladies de l'aorte/physiopathologie , Facteurs de risque , Sujet âgé , Études transversales , Appréciation des risques , Adulte , Indice de gravité de la maladie , Col du fémur/imagerie diagnostique , États-Unis/épidémiologie , République de Corée/épidémiologie , Ostéoporose/épidémiologie , Ostéoporose/imagerie diagnostique , Ostéoporose/diagnosticRÉSUMÉ
BACKGROUND AND AIMS: Coronary artery calcium (CAC) is validated for risk prediction among middle-aged adults, but there is limited research exploring implications of CAC among older adults. We used data from the Atherosclerosis Risk in Communities (ARIC) study to evaluate the association of CAC with domains of healthy and unhealthy aging in adults aged ≥75 years. METHODS: We included 2,290 participants aged ≥75 years free of known coronary heart disease who underwent CAC scoring at study visit 7. We examined the cross-sectional association of CAC = 0, 1-999 (reference), and ≥1000 with seven domains of aging: cognitive function, hearing, ankle-brachial index (ABI), pulse-wave velocity (PWV), forced vital capacity (FVC), physical functioning, and grip strength. RESULTS: The mean age was 80.5 ± 4.3 years, 38.6% male, and 77.7% White. 10.3% had CAC = 0 and 19.2% had CAC≥1000. Individuals with CAC = 0 had the lowest while those with CAC≥1000 had the highest proportion with dementia (2% vs 8%), hearing impairment (46% vs 67%), low ABI (3% vs 18%), high PWV (27% vs 41%), reduced FVC (34% vs 42%), impaired grip strength (66% vs 74%), and mean composite abnormal aging score (2.6 vs 3.7). Participants with CAC = 0 were less likely to have abnormal ABI (aOR:0.15, 95%CI:0.07-0.34), high PWV (aOR:0.57, 95%CI:0.41-0.80), and reduced FVC (aOR:0.69, 95%CI:0.50-0.96). Conversely, participants with CAC≥1000 were more likely to have low ABI (aOR:1.74, 95%CI:1.27-2.39), high PWV (aOR:1.52, 95%CI:1.15-2.00), impaired physical functioning (aOR:1.35, 95%CI:1.05-1.73), and impaired grip strength (aOR:1.46, 95%CI:1.08-1.99). CONCLUSIONS: Our findings highlight CAC as a simple measure broadly associated with biological aging, with clinical and research implications for estimating the physical and physiological aging trajectory of older individuals.
Sujet(s)
Maladie des artères coronaires , Calcification vasculaire , Humains , Mâle , Femelle , Sujet âgé , Sujet âgé de 80 ans ou plus , Études transversales , Maladie des artères coronaires/épidémiologie , Maladie des artères coronaires/physiopathologie , Maladie des artères coronaires/diagnostic , Calcification vasculaire/imagerie diagnostique , Calcification vasculaire/épidémiologie , Calcification vasculaire/physiopathologie , Index de pression systolique cheville-bras , Force de la main , Appréciation des risques , Vieillissement en bonne santé , États-Unis/épidémiologie , Cognition , Vaisseaux coronaires/imagerie diagnostique , Facteurs âges , Vieillissement , Analyse de l'onde de pouls , Facteurs de risque , Athérosclérose/épidémiologie , Athérosclérose/physiopathologie , Évaluation gériatrique , Capacité vitaleRÉSUMÉ
AIMS: The aim was to investigate the relationship between microvascular function, cardiovascular risk profile, and subclinical atherosclerotic burden. METHODS AND RESULTS: The study enrolled 3809 individuals, 50-65 years old, participating in the population-based observational cross-sectional Swedish CArdioPulmonary bioImage Study. Microvascular function was assessed in forearm skin using an arterial occlusion and release protocol determining peak blood oxygen saturation (OxyP). Cardiovascular risk was calculated using the updated Systematic Coronary Risk Evaluation [SCORE2; 10-year risk of fatal and non-fatal cardiovascular disease (CVD) events]. The OxyP was compared with coronary artery calcification score (CACS) and to plaques in the carotid arteries. Individuals with OxyP values in the lowest quartile (Q1; impaired microvascular function) had a mean SCORE2 of 5.8% compared with 3.8% in those with the highest values of OxyP (Q4), a relative risk increase of 53%. The risk of having a SCORE2 > 10% was five times higher for those in Q1 (odds ratio: 4.96, 95% confidence interval: 2.76-8.93) vs. Q4 when adjusting for body mass index and high-sensitivity C-reactive protein. The OxyP was lower in individuals with CACS > 0 and in those with both carotid plaques and CACS > 0, compared with individuals without subclinical atherosclerotic burdens (87.5 ± 5.6% and 86.9 ± 6.0%, vs. 88.6 ± 5.8%, P < 0.01). CONCLUSION: In a population without CVD or diabetes mellitus, impaired microvascular function is associated with cardiovascular risk profiles such as higher SCORE2 risk and CACS. We suggest that OxyP may serve as a microcirculatory functional marker of subclinical atherosclerosis and CVD risk that is not detected by structural assessments.
Impaired microvascular function was associated with higher cardiovascular risk profile SCORE2 and subclinical atherosclerotic burden defined by carotid plaque and coronary artery calcification score (CACS).Individuals with impaired microvascular function (peak oxygen saturation in the forearm skin, OxyP, after a prolonged arterial occlusion provocation) had a moderate risk level of SCORE2 compared to low risk level in those with the highest values of OxyP.The OxyP was lower in individuals with CACS > 0 and in those with both carotid plaques and CACS > 0, compared with individuals with carotid plaque only and in individuals without subclinical atherosclerotic burdens.
Sujet(s)
Artériopathies carotidiennes , Facteurs de risque de maladie cardiaque , Microcirculation , Humains , Adulte d'âge moyen , Mâle , Femelle , Suède/épidémiologie , Études transversales , Sujet âgé , Appréciation des risques , Artériopathies carotidiennes/physiopathologie , Artériopathies carotidiennes/épidémiologie , Maladie des artères coronaires/physiopathologie , Maladie des artères coronaires/épidémiologie , Saturation en oxygène , Plaque d'athérosclérose , Maladies asymptomatiques , Calcification vasculaire/physiopathologie , Calcification vasculaire/épidémiologie , Avant-bras/vascularisation , Facteurs de risque , Peau/vascularisation , Maladies cardiovasculaires/épidémiologie , Maladies cardiovasculaires/physiopathologie , Maladies cardiovasculaires/diagnostic , Facteurs âgesRÉSUMÉ
OBJECTIVES: The impact of coronary calcification on the diagnostic accuracy of computed tomography-derived fractional flow reserve (CT-FFR) and coronary computed tomography angiography (CCTA) remains a crucial consideration. This meta-analysis aims to compare the diagnostic performance of CT-FFR and CCTA at different levels of coronary artery calcium score (CACS). METHODS AND RESULTS: We searched PubMed, Embase, and the Cochrane Library for relevant articles on CCTA, CT-FFR, and invasive fractional flow reserve (FFR). Ten studies were included to evaluate the diagnostic performance of CT-FFR and CCTA at the per-patient and per-vessel levels in four CACS groups. Invasive FFR was used as the reference standard. Except for the CACS ≥ 400 group, the AUC of CT-FFR was higher than those of CCTA in other subgroups of CACS (in CACS < 100 (per-patient, 0.9 (95% CI 0.87-0.92) vs. 0.32 (95% CI 0.28-0.36); per-vessel, 0.92 (95% CI 0.89-0.94) vs. 0.66 (95% CI 0.62-0.7); both p < 0.001), CACS ≥ 100 (per-patient, 0.86 (95% CI 0.82-0.88) vs. 0.44 (95% CI 0.4-0.48); per-vessel, 0.88 (95% CI 0.85-0.9) vs. 0.51 (95% CI 0.46-0.55); both p < 0.001), and CACS < 400 (per-patient, 0.9 (95% CI 0.87-0.93) vs. 0.74 (95% CI 0.7-0.78), p < 0.001; per-vessel, 0.8 (95% CI 0.76-0.83) vs. 0.74 (95% CI 0.7-0.78); p = 0.02)). CONCLUSIONS: CT-FFR demonstrates superior diagnostic performance in low CACS groups (CACS < 400) than CCTA in detecting hemodynamic stenoses in patients with coronary artery disease (CAD). CLINICAL RELEVANCE STATEMENT: Computed tomography-derived fractional flow reserve might be utilized to determine the necessity of invasive coronary angiography in coronary artery disease patients with coronary artery calcium score < 400. KEY POINTS: ⢠There is a lack of meta-analysis comparing the diagnostic performance of computed tomography-derived fractional flow reserve and coronary computed tomography angiography at different levels of calcification. ⢠Computed tomography-derived fractional flow reserve only has a better diagnostic performance than coronary computed tomography angiography with low amounts of coronary calcium. ⢠For the low coronary artery calcium score group, computed tomography-derived fractional flow reserve might be a good non-invasive method to detect hemodynamic stenoses in coronary artery disease patients.
Sujet(s)
Angiographie par tomodensitométrie , Coronarographie , Maladie des artères coronaires , Fraction du flux de réserve coronaire , Calcification vasculaire , Humains , Fraction du flux de réserve coronaire/physiologie , Angiographie par tomodensitométrie/méthodes , Maladie des artères coronaires/imagerie diagnostique , Maladie des artères coronaires/physiopathologie , Coronarographie/méthodes , Calcification vasculaire/imagerie diagnostique , Calcification vasculaire/physiopathologie , Tomodensitométrie/méthodes , Vaisseaux coronaires/imagerie diagnostique , Vaisseaux coronaires/physiopathologieRÉSUMÉ
Primary hyperparathyroidism (PHPT) is presented in various forms, including classic PHPT, characterised by increased parathyroid hormone (PTH) secretion, normohormonal PHPT, and normocalcaemic PHPT. Secondary hyperparathyroidism is characterised by increased PTH secretion triggered by factors such as vitamin D deficiency and kidney failure. This review aims to discuss the involvement of hyperparathyroidism (HPT) in atherosclerosis, including peripheral arterial disease (PAD). The increased level of PTH is involved in developing subclinical and overt vascular diseases, encompassing endothelial dysfunction, vascular stiffness, hypertension, and coronary and peripheral arterial diseases. It has been consistently associated with an augmented risk of cardiovascular morbidity and mortality, independent of classical risk factors for atherosclerosis. Chronic hypercalcemia associated with increased levels of PTH contributes to the development of calcification of vessel walls and atherosclerotic plaques. Vascular calcification can occur in the intima or media of the arterial wall and is associated with stiffness of peripheral arteries, which the formation of atherosclerotic plaques and narrowing of the vessel lumen can follow. For treating hyperparathyroidism, particularly SHPT, calcimimetics, novel phosphorus binders and novel vitamin D receptor activators are used. However, they are ineffective in severe PHPT. Therefore, parathyroidectomy remains the primary therapeutic option of PHPT.
Sujet(s)
Hyperparathyroïdie primitive , Hormone parathyroïdienne , Maladie artérielle périphérique , Humains , Maladie artérielle périphérique/physiopathologie , Hyperparathyroïdie primitive/physiopathologie , Hyperparathyroïdie primitive/complications , Hyperparathyroïdie primitive/diagnostic , Hormone parathyroïdienne/sang , Animaux , Facteurs de risque , Parathyroïdectomie , Calcification vasculaire/physiopathologie , Calcification vasculaire/étiologie , Hyperparathyroïdie secondaire/étiologie , Hyperparathyroïdie secondaire/physiopathologie , Résultat thérapeutique , Marqueurs biologiques/sang , Pronostic , Calcium/métabolisme , Calcium/sangRÉSUMÉ
Fundamento: As calcificações de artérias coronárias (CAC) mostram-se como fator preditivo de doenças cardiovasculares (DCV). A tomografia computadorizada (TC) de tórax com protocolo de aquisição de baixa dose apresenta acurácia na identificação de CAC e propicia achados incidentais dessas calcificações, que são comumente negligenciados. Este estudo analisará a prevalência de achados incidentais de calcificação em artérias coronárias em indivíduos não cardiopatas submetidos à TC de tórax. Métodos: Estudo transversal consecutivo de caráter analítico e descritivo. Foram incluídos indivíduos de ambos os sexos que realizaram TC de tórax por encaminhamento, acima de 18 anos e não cardiopatas. A coleta de dados foi realizada por meio de prontuários e ficha de anamnese auto aplicada. As variáveis referentes às CAC e à extensão do comprometimento foram obtidas a partir da reavaliação das imagens de TC de tórax disponíveis no sistema da instituição. Os exames foram anonimizados e avaliados por dois médicos radiologistas experientes. Considerou-se como estatisticamente significativo p≤0,05. Resultados: Foram analisados 397 exames. Encontrou-se prevalência de calcificações em 176 (44%) dos casos. A existência dessas calcificações coronárias está relacionada à idade (p<0,001). As calcificações possuem relação com o sexo (p = 0,03) com maior razão de chance de desenvolvimento em homens (odds ratio [OR] = 1,55). O tabagismo (p<0,001), o sedentarismo (p<0,001), a hipertensão arterial sistêmica (p<0,001), o diabetes mellitus (p = 0,04) e as dislipidemias (p<0,001) mostraram associação positiva. Conclusão: A prevalência de achados incidentais de CAC foi de 44%; variam em maior número entre leve e grave; maior razão de chance no sexo masculino e aumento da prevalência com a idade. Portanto, a TC de tórax mostra-se um efetivo método para avaliar as CAC, e juntamente com a história clínica do paciente pode ser utilizada para medir os fatores de risco para doenças cardiovasculares e intervir no desfecho do quadro.(AU)
Introduction: Coronary artery calcifications (CAC) are shown to be a predictive factor of cardiovascular diseases. Computed tomography (CT) of the chest with a low-dose acquisition protocol is accurate in identifying CAC and provides incidental findings of these calcifications, which are commonly overlooked. This study will analyze the prevalence of incidental findings of calcification in coronary arteries in non-cardiac individuals undergoing chest CT. Methods: Consecutive cross-sectional study of an analytical and descriptive nature. Individuals of both genders who underwent chest CT by referral, over 18 years of age and without heart disease were included. Data collection was carried out using medical records and a self-applied anamnesis form. The variables referring to the CAC and the extension of the impairment were obtained from the reassessment of the chest CT images available in the institution's system. The exams were anonymized and evaluated by two experienced radiologists. P≤0.05 was considered statistically significant. Results: 397 exams were analyzed. A prevalence of calcifications was found in 176 (44%) of the cases. The existence of these coronary calcifications is related to age (p<0.001). Calcifications are related to gender (p = 0.03) with a higher odds ratio of development in men (odds ratio [OR] = 1.55). Smoking (p<0.001), sedentary lifestyle (p<0.001), systemic arterial hypertension (p<0.001), Diabetes Mellitus (p = 0.04), and dyslipidemia (p<0.001) showed a positive association. Conclusion: The prevalence of incidental CAC findings was 44%; vary in greater numbers between mild and severe; higher odds ratio in males and increased prevalence with age. Therefore, chest CT proves to be an effective method to assess CAC, and together with the patient's clinical history, it can be used to measure risk factors for CVD and intervene in the outcome of the condition.(AU)